| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DAVE | Class A Common Stock | Options Exercise | $11.5 K | +12 K | +36.32% | $0.96 | 45 K | Mar 5, 2024 | Direct | |
| transaction | DAVE | Class A Common Stock | Sale | -$384 K | -12 K | -26.64% | $32.02 | 33 K | Mar 5, 2024 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DAVE | Stock Option (right to buy) | Options Exercise | $0 | -12 K | -49.74% | $0.00 | 12.1 K | Mar 5, 2024 | Class A Common Stock | 12 K | $0.96 | Direct | F3, F4 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 5, 2023. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The amounts relating to this stock option have been adjusted to reflect the Issuer's 1-for-32 reverse stock split effected on January 5, 2023. |
| F4 | These options are fully vested and exercisable. |
Exhibit 24.1 - Power of Attorney